Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
SkinBioTherapeutics (SBTX) Share Price & Analysis
3 Followers
SBTX Stock Chart & Stats
Day’s Range9.5p - 9.87p
52-Week Range― - ―
Previous Close9.75p
Volume397.31K
Average Volume (3M)N/A
Market Cap
£19.54M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Nov 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding192,795,949
10 Day Avg. Volume2,216,555
30 Day Avg. Volume2,303,843
Standard Deviation0.35
R-Squared0.09
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)33.57
Price to Sales (P/S)96061.44
Price to Cash Flow (P/CF)-9.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.61%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
99.39% Public Companies and
Individual Investors
SBTX FAQ
What was SkinBioTherapeutics PLC’s price range in the past 12 months?
Currently, no data Available
What is SkinBioTherapeutics PLC’s market cap?
Currently, no data Available
When is SkinBioTherapeutics PLC’s upcoming earnings report date?
SkinBioTherapeutics PLC’s upcoming earnings report date is Nov 26, 2024 which is in 211 days.
How were SkinBioTherapeutics PLC’s earnings last quarter?
SkinBioTherapeutics PLC released its earnings results on Mar 22, 2024. The company reported -0.008p earnings per share for the quarter, missing the consensus estimate of N/A by -0.008p.
Is SkinBioTherapeutics PLC overvalued?
According to Wall Street analysts SkinBioTherapeutics PLC’s price is currently Overvalued.
Does SkinBioTherapeutics PLC pay dividends?
SkinBioTherapeutics PLC does not currently pay dividends.
What is SkinBioTherapeutics PLC’s EPS estimate?
SkinBioTherapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SkinBioTherapeutics PLC have?
Currently, no data Available
What happened to SkinBioTherapeutics PLC’s price movement after its last earnings report?
SkinBioTherapeutics PLC reported an EPS of -0.008p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 13.793%.
Which hedge fund is a major shareholder of SkinBioTherapeutics PLC?
Currently, no hedge funds are holding shares in GB:SBTX
---
SkinBioTherapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.83%
12-Months-Change
Fundamentals
Return on Equity
-118.64%
Trailing 12-Months
Asset Growth
111.81%
Trailing 12-Months
Company Description
SkinBioTherapeutics PLC
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage and restore skin utilizing proteins found in the human microbiota. SkinBioTherapeutics is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema. The company has one reportable segment namely the research and development of the SkinBiotix technology.
---
Technical Analysis
---